Prudential »

Halozyme Therapeutics shares owned by Prudential

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Prudential from 13F filings

Historical chart of Prudential investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Prudential consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Prudential

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.9M 39k 73.34
2025-06-30 $2.2M 43k 52.02
2025-03-31 $4.5M 70k 63.81
2024-12-31 $2.8M 58k 47.81
2024-09-30 $3.2M 56k 57.24
2024-06-30 $2.2M 42k 52.36
2024-03-31 $1.7M 42k 40.68